Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luke Wang

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
BJU International|November 2, 2023
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomyKevin Hakimi, Steven C Campbell, Mimi V Nguyen, et al.
World Journal of Urology|January 29, 2026
Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomesGiacomo Musso, Margaret F Meagher, Ryan Nasseri, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS bindersYao-Cheng Li, Nikki K Lytle, Seth T Gammon, et al.
Urologic Oncology|May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer DatabaseDhruv Puri, Brian R Lane, Natalie Birouty, et al.
Cancers|February 13, 2025
Characteristics and Outcomes of T1a Renal Cell Carcinoma Presenting with MetastasisLuke Wang, Melis Guer, Dhruv Puri, et al.
Haematologica|September 25, 2025
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry studyEliza Chung, Luke Wang, Cameron Wellard, et al.
Blood Advances|January 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature reviewLuke Wang, Eliza Chung, Cameron Wellard, et al.
Clinical Genitourinary Cancer|January 1, 2023
Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFRJulia H Yuan, Hajime Tanaka, Dattatraya Patil, et al.
International Journal of Molecular Sciences|September 27, 2025
Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World SettingRafael Morales-Grimany, Krinio Giannikou, Cesar Delgado, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
BJU International|November 2, 2023
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomyKevin Hakimi, Steven C Campbell, Mimi V Nguyen, et al.
World Journal of Urology|January 29, 2026
Partial nephrectomy for clinical T2b, T3a, and T3b renal mass: evaluating trifecta achievement and surgical outcomesGiacomo Musso, Margaret F Meagher, Ryan Nasseri, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 20, 2020
Analysis of RAS protein interactions in living cells reveals a mechanism for pan-RAS depletion by membrane-targeted RAS bindersYao-Cheng Li, Nikki K Lytle, Seth T Gammon, et al.
Urologic Oncology|May 9, 2025
Reclassification of pathologically upstaged T3a Renal Cell Carcinoma is associated with enhanced alignment of outcomes: Analysis of the National Cancer DatabaseDhruv Puri, Brian R Lane, Natalie Birouty, et al.
Cancers|February 13, 2025
Characteristics and Outcomes of T1a Renal Cell Carcinoma Presenting with MetastasisLuke Wang, Melis Guer, Dhruv Puri, et al.
Haematologica|September 25, 2025
Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry studyEliza Chung, Luke Wang, Cameron Wellard, et al.
Blood Advances|January 18, 2025
Definitions and use of tumor bulk in phase 3 lymphoma trials: a comprehensive literature reviewLuke Wang, Eliza Chung, Cameron Wellard, et al.
Clinical Genitourinary Cancer|January 1, 2023
Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFRJulia H Yuan, Hajime Tanaka, Dattatraya Patil, et al.
International Journal of Molecular Sciences|September 27, 2025
Molecular Features and Actionable Gene Targets of Testicular Germ Cell Tumors in a Real-World SettingRafael Morales-Grimany, Krinio Giannikou, Cesar Delgado, et al.
Urologic Oncology|February 10, 2024
Unraveling the BMI paradox in different renal cortical tumors: insights from the INMARC registryCesare Saitta, Jonathan A Afari, Arman Walia, et al.
Pageof 3